{"id":"W3082341997","doi":"10.1093/eurheartj/ehaa617","title":"Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Biosense Webster; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; Bayer HealthCare; Medicure; Boston Scientific Corporation; Deutsche Herzstiftung; Bristol-Myers Squibb; AstraZeneca; Servier; Amgen; Pfizer; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Edoxaban; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Acute coronary syndrome; Cardiology; Atrial fibrillation; Myocardial infarction; Hazard ratio; Clinical endpoint; Randomized controlled trial; Warfarin; Confidence interval; Dabigatran","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003413424,0.0001852145,0.0005077286,0.0002142933,0.0001260611,0.0000597041,0.000141135,0.00004303531,0.001020541],"category_scores_gemma":[0.0001334336,0.0001190973,0.0005795491,0.000842557,0.00005962222,0.000231258,0.00009987316,0.0002639453,0.00001701595],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001594298,"about_ca_system_score_gemma":0.00008542609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006363275,"about_ca_topic_score_gemma":0.000009806884,"domain_scores_codex":[0.9974905,0.0005947815,0.0007851365,0.0002599627,0.0006616366,0.0002080221],"domain_scores_gemma":[0.9989628,0.0001208265,0.0004674222,0.0002036954,0.000102622,0.0001426354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09918766,0.00003647568,0.8885704,0.00004639314,0.002120066,0.0003127075,0.0006514057,0.003690968,0.000178625,0.000006222177,0.002121773,0.003077288],"study_design_scores_gemma":[0.03000773,0.003497182,0.957375,0.0001024251,0.00185023,0.0003705286,0.00008927903,0.001546041,0.000009906114,0.00000151891,0.005014194,0.000135995],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995884,0.0001748028,0.0001612336,0.002007132,0.0004081493,0.001173468,0.00003033411,0.00002643951,0.0001344557],"genre_scores_gemma":[0.9976715,0.00008553267,0.000122639,0.0001027337,0.001044781,4.402739e-7,0.0001516302,0.00003194163,0.0007888103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06917993,"threshold_uncertainty_score":0.9998927,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04935026771025512,"score_gpt":0.3166852441811516,"score_spread":0.2673349764708964,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}